Recognizing genetic hemochromatosis.
This article reviews the disease process hemochromatosis, which is now recognized as one of the most common genetic disorders. Hemochromatosis is transmitted as autosomal recessive, and occurs in 3% of persons of Anglo-Saxon descent. It is caused by an inappropriate increase in intestinal iron absorption resulting in deposition of excess iron in tissues. Hemochromatosis usually presents in males in their 40s, and females much later. The most frequent initial symptoms are weakness, lassitude, weight loss, and symptoms related to the onset of diabetes mellitus. The classical triad of cirrhosis, diabetes mellitus, and skin pigmentation occurs late in the disease. There is debate over the value of mass screening for the disorder; however, it is recommended that once a case has been identified family members at risk should be screened. Therapy is directed at removing excess iron by phlebotomy. By instituting early therapy, many of the long-term complications, including cirrhosis and hepatoma, can be prevented. It is imperative that physicians learn to recognize early signs and symptoms of hemochromatosis so that treated patients can expect a normal life span with minimal medical intervention.
Tulane University School of Medicine program in Community Medicine, News Orleans, LA 70112.
F J
FJ
Welch
D001815:Bloodletting; D006432:Hemochromatosis / Q000209:etiology / Q000235:genetics* / Q000628:therapy; D006801:Humans; D007501:Iron / Q000097:blood; D008286:Malabsorption Syndromes / Q000150:complications
D007501:Iron